Parameter | Study one, n = 16, 2 females. | Study two, n = 19, all males | ||
---|---|---|---|---|
Age, years | 25 (21–29) | 28 (20–38) | ||
Height, cm | Males: 181 (173–195) Females: 171 (166–176.5) | 181 (168–190) | ||
Weight, kg | Males: 75 (67–88) Females: 69 (60–79) | 79 (55–97) | ||
BMI, kg/m2 | Males: 23 (20–25) Females: 23 (21–25) | 24 (19–29) | ||
Pre exposure measures | Petrodiesel | RME30 | Petrodiesel | RME100 |
Vital capacity, L | 5.8 ± 0.3 | 5.9 ± 0.3 | 6.3 ± 0.3 | 6.3 ± 0.3 |
FEV1, L | 4.6 ± 0.2 | 4.6 ± 0.2 | 4.8 ± 0.2 | 4.8 ± 0.2 |
FENO 50, ppb | 12 ± 1 | 11 ± 1 | 13 ± 1 | 15 ± 2 |
Systolic blood pressure, mm hg | 121 ± 3 | 123 ± 2 | 136 ± 3 | 135 ± 3 |
Diastolic blood pressure, mm hg | 69 ± 1 | 71 ± 1 | 79 ± 2 | 78 ± 2 |
Heart rate, bpm | 65 ± 2 | 64 ± 2 | 68 ± 2 | 67 ± 2 |
Hemoglobin, g/L | 148 ± 3 | 147 ± 3 | 151 ± 2 | 151 ± 2 |
Leukocyte particle concentration × 109/L | 5.7 ± 0.3 | 5.7 ± 0.4 | 5.4 ± 0.2 | 5.5 ± 0.3 |
Platelet concentration, ×109/L | 231 ± 11 | 236 ± 11 | 232 ± 11 | 230 ± 10 |
Lymphocytes, ×109/L | 2.1 ± 0.2 | 2.1 ± 0.2 | 2.2 ± 0.2 | 2.2 ± 0.2 |
Monocytes, ×109/L | 0.5 ± 0.0 | 0.5 ± 0.0 | 0.5 ± 0.0 | 0.5 ± 0.0 |
Neutrophils, ×109/L | 2.9 ± 0.2 | 3.0 ± 0.2 | 2.6 ± 0.1 | 2.6 ± 0.2 |